资讯

module reveals vulnerabilities in anaplastic large cell lymphoma”的研究报告中, 来自维也纳医科大学等机构的科学家们通过研究阐明,转录因子BATF3及其靶向基因 ...
2021年11月30日 讯 /生物谷BIOON/ --一种称之为间变性淋巴瘤激酶(ALK,anaplastic lymphoma kinase)的分子是多种癌症的驱动子,包括小儿神经母细胞瘤、B ...
Patients with anaplastic thyroid carcinoma can rarely be cured, but every effort should be made to prevent death due to suffocation. Between 1984 and 1999, 55 consecutive patients with anaplastic ...
Relationship of anaplastic thyroid cancer high tumor mutation burden and MSI-H status with response to anti-PD1 monotherapy. Authors: Saad A. Khan, Pamela Kurian, Bianca Mobley, Tam Burks, Muhammad ...
Source Reference: Cabanillas ME, et al "Anti-programmed death ligand 1 plus targeted therapy in anaplastic thyroid carcinoma: A nonrandomized clinical trial" JAMA Oncol 2024; DOI: 10.1001 ...
Original Article Published: 25 January 2008 Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder Anja C Roden ...
Ependymoma cancer is anaplastic if the cancer cells grow rapidly and are unusual in shape. Ependymomas can affect people of any age, though brain ependymomas commonly occur in children.
CHICAGO — As hope prevails for better outcomes in the management of anaplastic thyroid cancer, experts here at the 89th American Thyroid Association (ATA) Annual Meeting previewed forthcoming ...
Breast implant–associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around breast implants. The optimal management of this disease has not been established ...
Report Highlights Pharmaceutical and Healthcare latest pipeline guide Anaplastic Oligoastrocytoma - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development ...
Crizotinib is recommended, within its marketing authorisation, as an option for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer in adults. The drug is ...
NICE is unable to make a recommendation about the use in the NHS of alectinib for anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer previously treated with crizotinib. This is ...